Your session is about to expire
← Back to Search
Mistletoe Immunotherapy for Osteosarcoma
Study Summary
This trial is to test a possible cancer treatment for patients with osteosarcoma who had surgery to remove all gross disease from their lungs. It involves using Iscador® P at different concentrations and monitoring with CT scans.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I had radiation therapy within the last two weeks.I have recently undergone chemotherapy or immunotherapy.I am allergic to Iscador® P or similar products.I have another cancer besides osteosarcoma that is getting worse or needs treatment.I am currently on medication for an infection.I have active brain metastases or cancer in the lining of my brain.I haven't had cancer in the last 5 years, except for specific skin or cervical conditions.I have a history of certain immune or infectious diseases, or Crohn's disease.I am taking another chemotherapy drug during this study.I am not taking any drugs that affect my immune system.Side effects from my last cancer treatment have mostly gone away.I am mostly able to care for myself and carry out daily activities.I am between 8 and 29 years old.I have been diagnosed with osteosarcoma.I have a history of HIV or active hepatitis B/C.My osteosarcoma has returned in a place other than my lung.My liver, white blood cells, platelets, and kidney functions are within normal ranges.I agree to use effective birth control.My cancer returned in the lung after surgery to remove all visible signs of it.I had surgery to remove lung metastases within the last 8 weeks.I can receive shots under my skin.My cancer spread has been confirmed by lab tests.
- Group 1: Treatment Arm - Iscador*P
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the Treatment Arm been sanctioned by the FDA?
"Since this is a Phase 2 trial, signifying the absence of efficacy data yet presence of safety information, we tentatively rate Treatment Arm's security as a 2."
Is it possible to partake in this scientific research?
"Individuals that meet the criteria of having recurrent osteogenic sarcoma and are between 8 to 30 years old may be eligible for this trial. 32 participants in total must be recruited to complete it."
Are any new participants being sought to partake in this research experiment?
"Clinicaltrials.gov reports that, although initially launched on March 1st 2023 and most recently updated February 3rd, this trial is not actively looking for participants. However, there are currently 499 other studies seeking enrolment from the public."
Does the age restriction for this research preclude minors?
"The qualifications for this trial necessitate that participants are between the ages of 8 and 30. There are 199 medical studies suitable for patients younger than 18 years old, while 384 trials accommodate individuals 65 or older."
Share this study with friends
Copy Link
Messenger